Overview
Our mission is to save this generation of children and young adults with Duchenne muscular dystrophy.
CureDuchenne is recognized as the global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne.
We operate with integrity through compassion, and empowering the community nationally with positive solutions.
Our actions fuel hope for families, enable progress for drug development, and extend ambulation for patients in collaboration with pharmaceutical companies, medical and healthcare professionals, our scientific advisory board, and our board of directors.
Company News
CureDuchenne Ventures Announces The “CureDuchenne Ventures 2020 Pitch Contest”
Jun 10, 2020
Posted by CureDuchenne
Big News from CureDuchenne – Announcing New Partnership with Myosana Therapeutics
Apr 28, 2020
Posted by CureDuchenne